Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report
- PMID: 37746452
- PMCID: PMC10515475
- DOI: 10.7759/cureus.43969
Progressive Mitochondrial Encephalopathy Due to the Novel Compound Heterozygous Variants c.182C>T and c.446A>AG in NARS2: A Case Report
Abstract
Progressive mitochondrial encephalopathy manifesting as developmental delay, regression, epilepsy, myoclonus, dystonia, and spasticity due to a novel compound heterozygous variant in NARS2 has not been reported. The patient is a 3.5-year-old female with normal psychomotor development until she experienced her first generalized status epilepticus at 4.5 months of age. After seizure control, generalized myoclonus and psychomotor regression became evident. She suffered from two other epileptic states and seizure control remained inadequate despite the use of multiple anti-seizure drugs. Neurologic examination revealed generalized hypotonia, discoordination, unstable eye contact, drooling, open mouth, myoclonus, periodic torticollis, and ankle contractions. Cerebral MRI revealed hydrocephalus ex vacuo due to diffuse cortical and subcortical atrophy bilaterally and incomplete myelination. Genetic testing at 12 months of age revealed the compound heterozygous variants chr11: 78204182C>T and chr11: 78282446A>AG in NARS2. Despite anti-seizure drugs, mitochondrial cocktail, and cannabidiol, the disease progressed to intractable seizures and severe tetraspasticity. In summary, this case demonstrates that compound heterozygous variants in NARS2 can phenotypically manifest exclusively in the brain with intractable epilepsy, myoclonus, developmental delay, regression, hypotonia, cerebral atrophy, and hypomyelination, followed by tetraspasticity and dystonia.
Keywords: epilepsy; mitochondrial; mitochondrial encephalopathy; myoclonus; nars2; respiratory chain; spasticity.
Copyright © 2023, Finsterer et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Compound heterozygous variants of the NARS2 gene in siblings with refractory seizures: two case report and literature review.Front Pediatr. 2025 Apr 8;13:1571426. doi: 10.3389/fped.2025.1571426. eCollection 2025. Front Pediatr. 2025. PMID: 40264468 Free PMC article.
-
[DNM1L gene variant caused encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1: three cases report and literature review].Zhonghua Er Ke Za Zhi. 2021 May 2;59(5):400-406. doi: 10.3760/cma.j.cn112140-20200921-00893. Zhonghua Er Ke Za Zhi. 2021. PMID: 33902225 Review. Chinese.
-
Lethal NARS2-Related Disorder Associated With Rapidly Progressive Intractable Epilepsy and Global Brain Atrophy.Pediatr Neurol. 2018 Dec;89:26-30. doi: 10.1016/j.pediatrneurol.2018.07.014. Epub 2018 Aug 4. Pediatr Neurol. 2018. PMID: 30327238
-
Compound heterozygous variants of the NARS2 gene in siblings with developmental delay, epilepsy, and neonatal diabetes syndrome.Am J Med Genet A. 2022 Aug;188(8):2466-2471. doi: 10.1002/ajmg.a.62873. Epub 2022 Jun 15. Am J Med Genet A. 2022. PMID: 35703918
-
Novel NARS2 variants in a patient with early-onset status epilepticus: case study and literature review.BMC Pediatr. 2024 Feb 3;24(1):96. doi: 10.1186/s12887-024-04553-0. BMC Pediatr. 2024. PMID: 38310242 Free PMC article. Review.
Cited by
-
Demographic characteristics, diagnostic challenges, treatment patterns, and caregiver burden of mitochondrial diseases: a retrospective cross-sectional study.Orphanet J Rare Dis. 2024 Aug 2;19(1):287. doi: 10.1186/s13023-024-03289-5. Orphanet J Rare Dis. 2024. PMID: 39095827 Free PMC article.
-
Compound heterozygous variants of the NARS2 gene in siblings with refractory seizures: two case report and literature review.Front Pediatr. 2025 Apr 8;13:1571426. doi: 10.3389/fped.2025.1571426. eCollection 2025. Front Pediatr. 2025. PMID: 40264468 Free PMC article.
References
-
- A new entity in the NARS2 variant: the first reported case of type 1 diabetes mellitus associated with the phenotype. Cokyaman T, Cetin H, Dogan D, Silan F. J Trop Pediatr. 2022;69:0. - PubMed
-
- Toward the full set of human mitochondrial aminoacyl-tRNA synthetases: characterization of AspRS and TyrRS. Bonnefond L, Fender A, Rudinger-Thirion J, Giegé R, Florentz C, Sissler M. Biochemistry. 2005;44:4805–4816. - PubMed
-
- Splicing variants in NARS2 are associated with milder phenotypes and intra-familial variability. Ait-El-Mkadem Saadi S, Kaphan E, Morales Jaurrieta A, et al. Eur J Med Genet. 2022;65:104643. - PubMed
Publication types
LinkOut - more resources
Full Text Sources